25 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Kilitch Drugs (India) Ltd.

BSE

  • 45.60 -0.05 (-0.11%)
  • Vol: 2313
  • BSE Code: 524500
  • PREV. CLOSE
    45.65
  • OPEN PRICE
    46.35
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • 45.55 0.00 (0%)
  • Vol: 2719
  • NSE Code: KILITCH
  • PREV. CLOSE
    45.55
  • OPEN PRICE
    45.70
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    0.00(0)

Kilitch Drugs (India) Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
06-Feb-201713-Feb-2017 Kilitch Drugs India Ltd has informed that in furtherance of the matters proposed in the Board meeting to be held on February 13, 2017, at the Administrative Office of the Company at Mumbai at 4.00 P.M., for which the intimation was already given, the following additional matter is also proposed to be discussed and considered: - To consider grant of additional options to the employees of the Company under ESOP Scheme.
09-Nov-201614-Nov-2016
11-Aug-201612-Aug-2016 Quarterly Results & Kilitch Drugs India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on August 12, 2016, inter alia, to consider the following; 1. To take on record the Unaudited (Provisional] Financial Results for the Quarter ended June 30, 2016 along with the Limited Review Report; 2. To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2015-2016; 3. To finalize the dates of Book Closure for the purpose of forthcoming 24th Annual General Meeting; 4. To finalize the date, venue and time for convening 24th Annual General Meeting of the Members of the Company; 5. To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the 24th Annual General Meeting;
24-May-201630-May-2016 Audited Results
09-Mar-201611-Mar-2016 The Board of Directors of the Company will be held on March 11, 2016, inter alia, to consider entering into an Agreement with respect to capital contribution with Arham Neeta Realities LLP,.
02-Feb-201612-Feb-2016 Quarterly Results & The Board of Directors of the Company will be held on February 12, 2016, inter alia, to consider and take on record the following matters: 1. Unaudited (Provisional) Financial Result for the quarter ended December 31, 2015 along with the Limited Review Report as submitted by the Statutory Auditors of the Company. 2. Adoption of SEBI (Listing Obligations and Disclosure Requirements] Regulations, 2015 including authorizing any Director of the Company to enter into amended Listing Agreement and submission of the same to BSE & NSE and any other applicable authorities, if required.
05-Nov-201511-Nov-2015 Quarterly Results
12-Aug-201514-Aug-2015 Quarterly Results & The meeting of the Board of Directors of the Company will be held on August 14, 2015, inter alia: 1. To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2015 along with the Limited Review Report; 2. To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2014-2015; 3. To finalize the dates of Book Closure for the purpose of forthcoming 23rd Annual General Meeting; 4. To finalize the date, venue and time for convening 23rd Annual General Meeting of the Members of the Company; 5. To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the 23rd Annual General Meeting.
21-May-201528-May-2015 Audited Results
21-Apr-201527-Apr-2015 Kilitch Drugs India Ltd has informed that a meeting of the Board of Directors of the Company will be held on April 27, 2015, inter alia, to consider and approve the terms of settlement arrived at by the Company with Aura Pharmaceuticals Inc.
07-Apr-201514-Apr-2015 The Board of Directors of the Company will be held on April 14, 2015, inter alia, to transact the following: 1. To consider conducting Postal Ballot of the Company pursuant to Section 110 of the Companies Act, 2013 and rules prescribed thereunder and to finalize the Notice of Postal Ballot for seeking shareholders approval pertaining to the appointment of Mr. Ramesh Modi as an Independent Director of the Company. 2. To consider appointment of Scrutinizer to oversee the Postal Ballot process of the Company. 3. To consider delisting of the Company’s securities from National Stock Exchange of India Limited.
03-Feb-201512-Feb-2015 Quarterly Results
06-Aug-201414-Aug-2014 Quarterly Results & Kilitch Drugs India Ltd has informed that a meeting of the Board of Directors of the Company will be held on August 14, 2014, inter alia: 1. To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2014. 2. To adopt and approve the Notice and Directors' Report of the Company along with the Corporate Governance Report for financial year 2013-2014; 3. To finalize the dates of Book Closure for the purpose of forthcoming 22nd Annual General Meeting; 4. To finalize the date venue and time for convening 22nd Annual General Meeting of the Members of the Company; 5. To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the 22nd Annual General Meeting. Further, as per the Company's Code of Conduct for Prohibition of insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the Trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the Quarter ended June 30, 2014 from August 01, 2014 to August 14, 2014. Accordingly, all the Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window.